Size	Price	VIP Price	US Stock	Global Stock	In Stock
{[ item.pr_size ]}		Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

CAS No. :	488832-69-5
Formula :	C₁₉H₂₀N₄O₂S₂
M.W :	400.52
SMILES Code :	O=C(NN(C)C(C1=CC=CC=C1)=S)CC(NN(C)C(C2=CC=CC=C2)=S)=O
Synonyms :	STA-4783
MDL No. :	MFCD12911784
InChI Key :	BKJIXTWSNXCKJH-UHFFFAOYSA-N
Pubchem ID :	300471

GHS Pictogram:
Signal Word:	Warning
Hazard Statements:	H302-H315-H319-H335
Precautionary Statements:	P261-P305+P351+P338

ATP7A KO B16 melanoma cell line	1 nM		Partially rescued tyrosinase activity	PMC7304446
Fibroblasts from a patient with SCO2 mutations	0.1 nM - 1 nM	3 or 6 days	Partially rescued COX2 levels	PMC6094114
Mouse embryonic fibroblasts (MEFs)	0.1 nM - 5 nM	3 days	Rescued COX1 levels	PMC6094114
Rat H9c2 cardiomyocytes	0.1 nM - 5 nM	3 days	Rescued COX1 levels	PMC6094114
Ctr1 knockout H9c2 rat cardiomyocytes	1 nM		Restored oxygen consumption rate (OCR) and ATP levels, OCR restored to 103% of wild-type, ATP levels significantly increased	PMC7304446
ABC1 cells	40 nM	2 h	To investigate whether copper ionophore-mediated cell death is regulated, the results showed that short-term exposure to Elesclomol led to a significant increase in intracellular copper levels and triggered cell death more than 24 h later.	PMC9273333
B16 mouse melanoma cells	0.4 μg/mL	24 h	To evaluate the cytotoxicity of ES@CuO on B16 tumor cells, results showed that ES@CuO significantly inhibited tumor cell growth.	PMC11095170
4T1 cells	74.75 nM	24 h	To evaluate the antitumor activity of ECPCP on 4T1 cells, the results showed that ECPCP had an IC50 value of 74.75 nM, exhibiting the strongest cytotoxicity.	PMC11187900
4T1 cells	100 nM, 1 μM	24 h	Evaluate the antitumor activity of Elesclomol in 4T1 cells, results showed that Elesclomol significantly enhanced cytotoxicity in the presence of CuCl2, inducing Cu-dependent cell death.	PMC11791997
QBC939 cells	10 nM	48 h	To investigate the effect of Elesclomol and copper ion mixture (elesclomol-Cu) on cell death, results showed that elesclomol-Cu induced cell death, and the combination with ferroptosis inducers (such as sorafenib and erastin) enhanced cell death.	PMC10242978
MHCC-97 H cells	10 nM	48 h	To investigate the effect of Elesclomol and copper ion mixture (elesclomol-Cu) on cell death, results showed that elesclomol-Cu induced cell death, and the combination with ferroptosis inducers (such as sorafenib and erastin) enhanced cell death.	PMC10242978
GSC-derived endothelial cells (GdECs)	10, 100, 1000 nM	48 h	Elesclomol induced cell death in GdECs, increased mitochondrial reactive oxygen species (ROS) levels, leading to non-apoptotic copper-dependent cell death.	PMC8273992
Glioblastoma stem-like cells (GSCs)	10, 100, 1000 nM	48 h	Elesclomol induced cell death in GSCs, increased mitochondrial reactive oxygen species (ROS) levels, leading to non-apoptotic copper-dependent cell death.	PMC8273992
HCT116 cells	0 to 100 μM	24 h	To assess the impact of Elesclomol on cell viability, results showed the sensitivity of HCT116 cells to Elesclomol.	PMC11663789
Yeast coa6Δ cells	0.8 nM		Rescued respiratory growth defects by increasing mitochondrial copper content and restoring CcO activity	PMC6094114

Mice	Cardiac-specific Ctr1 KO mouse	Subcutaneous injection	10 mg/kg	Not specified	ES treatment significantly improved survival rate, restored heart and spleen weights, partially reduced cardiac hypertrophy, and increased cardiac copper levels and COX1 levels	PMC7304446
C57BL/6N mice	B16 tumor model	Intravenous injection	100 μg/mouse	Every 2 days for a total of 3 times	To evaluate the antitumor effect of ES@CuO in the B16 tumor model, results showed that ES@CuO significantly inhibited tumor growth.	PMC11095170
Balb/c mice	4T1 tumor model	Intravenous injection	5 mg/kg	Every other day for four times	To evaluate the antitumor efficacy of ECPCP in vivo, the results showed that ECPCP significantly inhibited tumor growth with an inhibition rate of 74.8%.	PMC11187900
Nude mice	MHCC-97 H and QBC939 xenograft model	Intraperitoneal injection	40 mg/kg	Five times a week, continuously monitored	To investigate the inhibitory effect of Elesclomol and copper ion mixture (elesclomol-Cu) combined with sorafenib on hepatocellular carcinoma and intrahepatic cholangiocarcinoma in vivo, results showed that the combination significantly inhibited tumor growth.	PMC10242978
NOD-SCID mice	Glioblastoma xenograft model	Intraperitoneal injection	25 mg/kg	Three times per week for three weeks	Elesclomol alone or in combination with temozolomide (TMZ) significantly inhibited tumor growth, and the combination therapy was more effective than TMZ alone.	PMC8273992
Zebrafish	Ctr1 mutant zebrafish	Incubation in water	10 nM	From 3 hpf onwards	Rescued pigmentation defects and Cox1 levels	PMC6094114
BALB/cAnN-Foxn1nu/nu/Rj nude mice	22Rv1 xenografts	Intravenous injection	25–37 MBq	Single or multiple doses, lasting 21 days	Evaluate the therapeutic effects of [64Cu][Cu(ES)] in vivo, results showed [64Cu][Cu(ES)] significantly inhibited tumor growth	PMC10547809

{[proInfo.proName]}

CAS No.: 488832-69-5

{[proInfo.proName]}

CAS No.: 488832-69-5

Alternative Products

Product Details of Elesclomol

Safety of Elesclomol

Related Pathways of Elesclomol

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

NCT00088088	Stage IIIB Non-Small Cell Lung... More >> Cancer Stage IV Non-Small Cell Lung Cancer Less <<	Phase 1 Phase 2	Completed	-	United States, Arkansas ... More >> NEA Clinic Jonesboro, Arkansas, United States, 72401 United States, California Wilshire Oncology Medical Group Pamona, California, United States, 91767 St. Francis Memorial Hospital San Francisco, California, United States Cancer Institute Medical Group Santa Monica, California, United States, 90404 Kaiser Permanete Vallejo, California, United States United States, Connecticut Oncology Associates of Bridgeport Trumball, Connecticut, United States, 06611 United States, Florida ACORN Miami, Florida, United States Oncology Hematology Consultants Sarasota, Florida, United States, 34236 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 The Cancer Institute at Alexian Brothers Elk Grove Village, Illinois, United States, 60007 Ingalls Hospital Harvey, Illinois, United States, 60426 United States, Louisiana Overton Brooks, VAMC Shreveport, Louisiana, United States, 71101 LSUHSC - Shreveport Feist Weiller Cancer Center Shreveport, Louisiana, United States, 71130 United States, Maryland Maryland Hematology and Oncology Associates Baltimore, Maryland, United States, 21236 United States, Minnesota The Duluth Clinic Duluth, Minnesota, United States, 55805 United States, Tennessee The West Clinic Memphis, Tennessee, United States, 38120 The Sarah Cannon Research Center Nashville, Tennessee, United States, 37203 United States, Texas Presbyterian Hospital Dallas, Texas, United States, 75231 United States, Washington Multicare Health System Tacoma, Washington, United States, 98405 Less <<
NCT00087997	Soft Tissue Sarcoma	PHASE2	COMPLETED	2025-10-05	Arizona Cancer Center, Scottsd... More >>ale, Arizona, 85258, United States\|Arizona Cancer Center, Tucson, Arizona, 85724, United States\|UCLA, Los Angeles, California, 90095, United States\|Yale University School of Medicine, New Haven, Connecticut, 06520, United States\|University of Florida, Gainesville, Florida, 32610, United States\|H. Lee Moffitt Cancer Center, Tampa, Florida, 33612, United States\|Palm Beach Cancer Institute, West Palm Beach, Florida, 33401, United States\|Winship Cancer Institute, Atlanta, Georgia, 30322, United States\|University of Chicago Department of Medicine, Chicago, Illinois, 60637, United States\|Via Christi Regional Med. Center (Wichita CCOP), Wichita, Kansas, 67214, United States\|University of Louisville Hospital, Louisville, Kentucky, 40202, United States\|Feist-Weiller Cancer Center, Shreveport, Louisiana, 71103, United States\|Dana-Farber Cancer Institute, Boston, Massachusetts, 02115, United States\|University of Michigan, Ann Arbor, Michigan, 48109, United States\|Wayne State University, Detroit, Michigan, 48201, United States\|Genesys Hurley Cancer Institute, Flint, Michigan, 48503, United States\|Washington University School of Medicine, St. Louis, Missouri, 63110, United States\|University of Nebraska Medical Center, Omaha, Nebraska, 68198, United States\|NYU Cancer Institute Clinical Center, New York, New York, 10016, United States\|Herbert Irving Cancer Center, New York, New York, 10032, United States\|Carolinas Medical Center/Blumenthal Cancer Center, Charlotte, North Carolina, 28203, United States\|Oregon Health and Science University, Portland, Oregon, 97239, United States\|Hillman Cancer Center, Pittsburg, Pennsylvania, 15232, United States\|The West Clinic, Memphis, Tennessee, 38120, United States\|The Sarah Cannon Cancer Center, Nashville, Tennessee, 37203, United States\|MD Anderson Cancer Center, Houston, Texas, 77030, United States\|Mount Sinai Hospital, Toronto, Ontario, M5G 1X5, Canada Less <<
NCT00522834	Melanoma	Phase 3	Terminated	-	-
NCT00088114	Neoplasms	Phase 1	Completed	-	United States, Massachusetts ... More >> Beth Israel-Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 Less <<
NCT00827203	Metastatic Solid Tumors	Phase 1	Suspended	January 2011	United States, Maryland ... More >> Mayo Clinic Rochester, Maryland, United States, 55905 United States, Texas University of Texas Health Science Center, Cancer Therapy & Research Center, Institute for Drug Development San Antonio, Texas, United States, 78229 United States, Wisconsin University of Wisconsin Paul P. Carbone Comprehensive Cancer Center Madison, Wisconsin, United States, 53792 Less <<
NCT00888615	Fallopian Tube Clear Cell Aden... More >>ocarcinoma Fallopian Tube Endometrioid Adenocarcinoma Fallopian Tube Mucinous Adenocarcinoma Fallopian Tube Serous Adenocarcinoma Fallopian Tube Transitional Cell Carcinoma Ovarian Brenner Tumor Ovarian Clear Cell Adenocarcinoma Ovarian Endometrioid Adenocarcinoma Ovarian Mucinous Adenocarcinoma Ovarian Seromucinous Carcinoma Ovarian Serous Adenocarcinoma Ovarian Transitional Cell Tumor Primary Peritoneal Serous Adenocarcinoma Recurrent Fallopian Tube Carcinoma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Undifferentiated Fallopian Tube Carcinoma Undifferentiated Ovarian Carcinoma Less <<	Phase 2	Active, not recruiting	-	-
NCT00084214	Melanoma	Phase 1 Phase 2	Completed	-	-
NCT01280786	Acute Myeloid Leukemia	Phase 1	Unknown	August 2014	Canada, Ontario ... More >> Princess Margaret Hospital Toronto, Ontario, Canada, MSG 2M9 Less <<
NCT00808418	Prostate Cancer	Phase 1	Completed	-	United States, California ... More >> Pacific Coast Hematology/Oncology Medical Group Fountain Valley, California, United States, 92708 United States, Maryland Mayo Clinic Rochester, Maryland, United States, 55905 United States, North Dakota Mid Dakota Clinic Bismarck, North Dakota, United States, 58501 United States, Texas University of Texas Health Science Center, Cancer Therapy & Research Center, Institute for Drug Development San Antonio, Texas, United States, 78229 United States, Wisconsin University of Wisconsin Paul P. Carbone Comprehensive Cancer Center Madison, Wisconsin, United States, 53792 Less <<

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed